Peripheral and cognitive signs: delineating the significance of impaired catecholamine metabolism in Parkinson's disease progression

Authors

  • Michael F. Salvatore,

    Corresponding author
    1. Department of Pharmacology, Toxicology & Neuroscience, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA
    • Address correspondence and reprint requests to Michael F. Salvatore, Department of Pharmacology, Toxicology, & Neuroscience, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA. E-mail: msalva@lsuhsc.edu

    Search for more papers by this author
  • Elizabeth A. Disbrow,

    1. Department of Pharmacology, Toxicology & Neuroscience, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA
    2. Department of Neurology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA
    Search for more papers by this author
  • Marina E. Emborg

    1. Wisconsin National Primate Research Center and Department of Medical Physics, University of Wisconsin, Madison, Wisconsin, USA
    Search for more papers by this author

Abstract

Read the full articleA vesicular sequestration to oxidative deamination shift in myocardial sympathetic nerves in Parkinson's disease’ on page 219.

Ancillary